Instruction: TOPK (T-LAK-cell-originated protein kinase), a MAPKK-like serine/threonine kinase, is crucial for neural progenitor cells self-renewal, however, its function and molecular mechanism for cerebral ischemia reperfusion injury remains unknown. In this study, we demonstrated that phosphorylation of TOPK was increased in rat cortex following transient middle cerebral artery occlusion (tMCAO), and was colocalized with NeuN.
Instruction: TOPK (T-LAK-cell-originated protein kinase), a MAPKK-like serine/threonine kinase, is crucial for neural progenitor cells self-renewal, however, its function and molecular mechanism for cerebral ischemia reperfusion injury remains unknown. In this study, we demonstrated that phosphorylation of TOPK was increased in rat cortex following transient middle cerebral artery occlusion (tMCAO), and was colocalized with NeuN.
Methods and results: To clarify its function, TOPK was overexpressed in PC12 neuronal cells, western blot displays elevated levels of antioxidative proteins peroxiredoxin 1 (Prx-1), Prx-2, heme oxygenase 1 (HO-1) and MnSOD, along with the activity of total SOD, which is in line with inhibition of peroxidation product MDA and 3-Nitrotyrosine upon H 2 O 2 stimulation. As well, TOPK overexpression increased cell viability and reduced expression of Caspase-3 and Caspase-12 in PC12 cells upon H 2 O 2 exposure. Furthermore, p-ERK level was increased by TOPK overexpression, and antioxidative protection afforded by TOPK was abolished by blocking ERK pathway in PC12 cells. In vivo, intracerebroventricular injection of TOPK overexpression vector reduced the infarct volume and neuronal apoptosis after tMCAO, increased total SOD activity and decreased ROS production in the cortex.
Conclusion: Collectively, these data reveal that activating TOPK confers neuroprotection against focal cerebral ischemia reperfusion injury by its antioxidative effect partly through activating ERK pathway.
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The impact of comorbidity on event-related brain topography in patients presenting chronic tic disorders and tourette syndrome
Introduction: Tourette Syndrome (TS) is mainly characterized by motor (e.g. head jerking) and vocal (e.g. throat clearing) tics. However, up to 90% of patients also experience comorbid psychiatric conditions, most often obsessive-compulsive disorder (OCD) and/or attention deficit hyperactivity disorder (ADHD). These additional components majorly impact patients' functional, emotional and physiological experiences. To this day, studies have mainly focused on patients presenting tics without taking comorbid conditions into account. The present project thus aimed at investigating if comorbid conditions can affect electrophysiological recordings.
According to previous data, the amplitude of the EEG P300 component can discriminate between participants presenting distinctive symptoms. Hence, we hypothesized that comorbid conditions will have a reducing effect on the P300 component's peak amplitude.
Methods: A group of TS patients with clinical comorbidities (n = 12) was compared to a group of medication-naïve patients with uncomplicated tics (n = 12). Furthermore, both groups were also paired to control participants (n = 12) in regard to age, sex and educational level. The amplitude of the P300 component has been extracted from EEG by an averaging procedure synchronized to the stimulus within a classical Oddball paradigm; subsequently topographical maps of cortical activations were built.
Results/conclusion: The P300 analyses have revealed a reduction of the P300 amplitude in the frontal region for TS patients with comorbid symptoms when compared to control participants. Moreover, TS patients with uncomplicated tics did not significantly differ from the control group. In conclusion, our data suggest that the amount of information introduced in working memory might be affected by comorbid conditions in TS patients. 
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